AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11572297 — intervention group
Group type: COMPARATOR
Intervention: Z100 control
Number of subjects: 70
Study 11572297 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass-ionomer liner on the cavosurface margin
Number of subjects: 70
Study 11572297 — intervention group
Group type: EXPERIMENTAL
Intervention: Compomer/hybrid combination
Number of subjects: 70
Study 11572297 — intervention group
Group type: EXPERIMENTAL
Intervention: Flowable/hybrid combination
Number of subjects: 70
Study 11572297 — intervention group
Group type: EXPERIMENTAL
Intervention: Packable composite
Number of subjects: 70
Study 9554765 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro Stent I
Number of subjects: 93
Study 9554765 — intervention group
Group type: COMPARATOR
Intervention: Palmaz-Schatz stent
Number of subjects: 93
Study 7933494 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic lactated Ringer's solution (HLS) with sodium of 213 mEq.l‐1
Number of subjects: 14
Study 7933494 — intervention group
Group type: COMPARATOR
Intervention: Regular lactated Ringer's solution (control)
Number of subjects: 14
Study 3230151 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate-release verapamil (80 to 120 mg three times a day)
Number of subjects: 22
Study 3230151 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release verapamil (240 mg daily)
Number of subjects: 22
Study 3230151 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 30630788 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound shuanghua tablets combined with western drug therapy
Number of subjects: 140
Study 30630788 — intervention group
Group type: COMPARATOR
Intervention: Routine western drug therapy
Number of subjects: 140
Study 28610669 — intervention group
Group type: EXPERIMENTAL
Intervention: Riociguat (0.5-2.5 mg three times daily)
Number of subjects: 68
Study 28610669 — intervention group
Group type: EXPERIMENTAL
Intervention: Riociguat
Number of subjects: 68
Study 26209542 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 60
Study 26209542 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 60
Study 26209542 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60
Study 23902840 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled budesonide 400 µg/d plus aminophylline tablet (0.1 g, 3 times/day, oral administration)
Number of subjects: 280
Study 23902840 — intervention group
Group type: COMPARATOR
Intervention: Inhaled budesonide 320 µg/day plus formoterol 9 µg/day
Number of subjects: 280
Study 20876500 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid Stenting (CAS)
Number of subjects: 0
Study 20876500 — intervention group
Group type: COMPARATOR
Intervention: Carotid Endarterectomy (CEA)
Number of subjects: 0
Study 18254672 — intervention group
Group type: COMPARATOR
Intervention: D‐Stat Dry (wound dressing)
Number of subjects: 852
Study 18254672 — intervention group
Group type: COMPARATOR
Intervention: Mechanical closure devices (Angio‐Seal and StarClose)
Number of subjects: 852
Study 18254672 — intervention group
Group type: EXPERIMENTAL
Intervention: Angio‐Seal
Number of subjects: 852
Study 18254672 — intervention group
Group type: EXPERIMENTAL
Intervention: StarClose
Number of subjects: 852
Study 17036485 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal acupuncture
Number of subjects: 152
Study 17036485 — intervention group
Group type: COMPARATOR
Intervention: Shallow needling with short-needle
Number of subjects: 152
Study 14608586 — intervention group
Group type: EXPERIMENTAL
Intervention: Support for people after suicide attempt
Number of subjects: 0
Study 14608586 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term lithium treatment
Number of subjects: 0
Study 14608586 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of different strategies in a multi-level approach
Number of subjects: 0
Study 11307438 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium hydroxide intracanal dressing, applied for at least one week before finishing treatment at the second visit.
Number of subjects: 73
Study 11307438 — intervention group
Group type: COMPARATOR
Intervention: One-visit root canal treatment without calcium hydroxide dressing.
Number of subjects: 73
Study 9305334 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 3,600 mg/d
Number of subjects: 82
Study 9305334 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 300 mg/d
Number of subjects: 82
Study 8339577 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac output measurement by bioimpedance using the BoMed NCCOM3‐R7 monitor
Number of subjects: 50
Study 8339577 — intervention group
Group type: COMPARATOR
Intervention: Cardiac output measurement by thermodilution
Number of subjects: 50
Study 3830245 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (oral, 5.83 mg X kg‐1 lean body weight)
Number of subjects: 6
Study 3830245 — intervention group
Group type: COMPARATOR
Intervention: Placebo (50 mg citrate)
Number of subjects: 6
Study 31739991 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg/day and Bevacizumab 10 mg/kg every 14 days on a 28-day cycle
Number of subjects: 50
Study 31739991 — intervention group
Group type: COMPARATOR
Intervention: Everolimus and Bevacizumab
Number of subjects: 50
Study 30660860 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 s work - 4 min of rest (10:4)
Number of subjects: 42
Study 30660860 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 s work - 4 min of rest (30:4)
Number of subjects: 42
Study 30660860 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 s work - 2 min of rest (10:2)
Number of subjects: 42
Study 30660860 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 42
Study 28314503 — intervention group
Group type: EXPERIMENTAL
Intervention: Ex vivo lung perfusion (EVLP)
Number of subjects: 80
Study 28314503 — intervention group
Group type: COMPARATOR
Intervention: Control group (no EVLP)
Number of subjects: 80
Study 26151998 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo care from the mother before, during, and after heel blood collection
Number of subjects: 40
Study 26151998 — intervention group
Group type: COMPARATOR
Intervention: Conventional conditions during heel blood collection
Number of subjects: 40
Study 23239873 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric training for 14 weeks
Number of subjects: 24
Study 23239873 — intervention group
Group type: COMPARATOR
Intervention: Control group (no eccentric training)
Number of subjects: 24
Study 23239873 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric training
Number of subjects: 24
Study 21424399 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based Triple P parenting skills prevention program
Number of subjects: 821
Study 19149900 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivalent inactivated split virus influenza vaccine (TIV)
Number of subjects: 6203
Study 19149900 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6203
Study 17256446 — intervention group
Group type: EXPERIMENTAL
Intervention: Erdosteine with amoxicillin
Number of subjects: 158
Study 17256446 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin-placebo combination
Number of subjects: 158
Study 15514599 — intervention group
Group type: EXPERIMENTAL
Intervention: Symmetry connector (St Jude Medical, Inc, St Paul, Minn)
Number of subjects: 46
Study 15514599 — intervention group
Group type: COMPARATOR
Intervention: Sutured anastomoses
Number of subjects: 46
Study 11605922 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 354
Study 11605922 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 354
Study 11605922 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 354
Study 11605922 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup with preoperative renal impairment (Isoflurane)
Number of subjects: 354
Study 11605922 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup with preoperative renal impairment (Sevoflurane)
Number of subjects: 354
Study 11605922 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup with preoperative renal impairment (Propofol)
Number of subjects: 354
Study 9888618 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum
Number of subjects: 120
Study 9888618 — intervention group
Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 120
Study 7912163 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant tamoxifen therapy
Number of subjects: 871
Study 7912163 — intervention group
Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 871
Study 2544248 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium
Number of subjects: 8
Study 2544248 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG)
Number of subjects: 8
Study 2544248 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 20183661 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's Negative Cognitive Error Questionnaire (CNCEQ)
Number of subjects: 427
Study 417248 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte transfusions
Number of subjects: 69
Study 417248 — intervention group
Group type: COMPARATOR
Intervention: Control (no granulocyte transfusions)
Number of subjects: 69
Study 31937120 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol infusion in the vein of Marshall
Number of subjects: 147
Study 31937120 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency ablation
Number of subjects: 147
Study 31706866 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade G2 tumors
Number of subjects: 12415
Study 31706866 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade G3 tumors
Number of subjects: 12415
Study 31706866 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated grade-specific staging system
Number of subjects: 12415
Study 28157776 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based pain self-management program delivered by physical therapists (PTs)
Number of subjects: 320
Study 28157776 — intervention group
Group type: COMPARATOR
Intervention: Control group (PTs not receiving the intervention)
Number of subjects: 320
Study 26422093 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 5 mg
Number of subjects: 109
Study 26422093 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 10 mg
Number of subjects: 109
Study 26422093 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 10 mg (for children > 20 kg)
Number of subjects: 109
Study 26422093 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg (for children > 20 kg)
Number of subjects: 109
Study 26422093 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole (all doses)
Number of subjects: 109
Study 23274592 — intervention group
Group type: EXPERIMENTAL
Intervention: Astaxanthin (20 mg per day for 4 weeks)
Number of subjects: 32
Study 23274592 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 23274592 — intervention group
Group type: EXPERIMENTAL
Intervention: Astaxanthin
Number of subjects: 32
Study 21482348 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular weight heparin (LMWH) dalteparin 5000 IU once daily
Number of subjects: 0
Study 21482348 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH) 5000 IU subcutaneous injection
Number of subjects: 0
Study 19241327 — intervention group
Group type: EXPERIMENTAL
Intervention: Scan delay of 85 sec (protocol 3 and 4)
Number of subjects: 57
Study 19241327 — intervention group
Group type: EXPERIMENTAL
Intervention: Scan delay of 65 sec
Number of subjects: 57
Study 19241327 — intervention group
Group type: EXPERIMENTAL
Intervention: Scan delay of 75 sec
Number of subjects: 57
Study 19241327 — intervention group
Group type: EXPERIMENTAL
Intervention: Scan delay of 95 sec
Number of subjects: 57
Study 17124241 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimatoprost
Number of subjects: 129
Study 17124241 — intervention group
Group type: COMPARATOR
Intervention: Latanoprost
Number of subjects: 129
Study 15019387 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined peribulbar and retrobulbar anesthesia
Number of subjects: 15
Study 15019387 — intervention group
Group type: EXPERIMENTAL
Intervention: Superomedial retrobulbar injection
Number of subjects: 15
Study 15019387 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub‐Tenon's injection
Number of subjects: 15
Study 12038910 — intervention group
Group type: EXPERIMENTAL
Intervention: Written feedback from editors (intervention)
Number of subjects: 222
Study 12038910 — intervention group
Group type: COMPARATOR
Intervention: Control group (receiving other reviewers' unscored reviews and the editor's decision letter)
Number of subjects: 222
Study 9709766 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-zone LASIK
Number of subjects: 95
Study 9709766 — intervention group
Group type: EXPERIMENTAL
Intervention: Multizone LASIK
Number of subjects: 95
Study 9709766 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 95
Study 7661591 — intervention group
Group type: EXPERIMENTAL
Intervention: RT concomitant chemo, no maintenance (Arm 3)
Number of subjects: 673
Study 7661591 — intervention group
Group type: EXPERIMENTAL
Intervention: RT concomitant chemo, with maintenance (Arm 4)
Number of subjects: 673
Study 7661591 — intervention group
Group type: EXPERIMENTAL
Intervention: RT alone with maintenance chemotherapy (Arm 2)
Number of subjects: 673
Study 7661591 — intervention group
Group type: COMPARATOR
Intervention: RT alone (Arm 1)
Number of subjects: 673
Study 2679865 — intervention group
Group type: EXPERIMENTAL
Intervention: Gestational diabetes
Number of subjects: 261
Study 2679865 — intervention group
Group type: COMPARATOR
Intervention: Reference group
Number of subjects: 261
Study 1106350 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 28
Study 1106350 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 31244327 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated programme of physical and electrical therapy
Number of subjects: 95
Study 31244327 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 95
Study 29378994 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA)
Number of subjects: 25
Study 29378994 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 25
Study 25371064 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicycling (exercise condition)
Number of subjects: 136
Study 25371064 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric arm and leg exercises
Number of subjects: 136
Study 25371064 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise condition (control)
Number of subjects: 136
Study 23362167 — intervention group
Group type: EXPERIMENTAL
Intervention: Compliance-guided PEEP group
Number of subjects: 70
Study 23362167 — intervention group
Group type: COMPARATOR
Intervention: FIO2-guided group
Number of subjects: 70
Study 21215828 — intervention group
Group type: EXPERIMENTAL
Intervention: DTaP-IPV (Tetraxim™)
Number of subjects: 442
Study 21215828 — intervention group
Group type: COMPARATOR
Intervention: DTaP and IPV vaccines (separate administration)
Number of subjects: 442
Study 19957670 — intervention group
Group type: EXPERIMENTAL
Intervention: Anethol trithione
Number of subjects: 80
Study 19957670 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study 16848268 — intervention group
Group type: COMPARATOR
Intervention: Conventional film radiography
Number of subjects: 12
Study 16848268 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital original radiography
Number of subjects: 12
Study 16848268 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital inverse radiography
Number of subjects: 12
Study 12931761 — intervention group
Group type: EXPERIMENTAL
Intervention: Ridge preservation (RP) using tetracycline hydrated freeze-dried bone allograft (FDBA) and a collagen membrane
Number of subjects: 24
Study 12931761 — intervention group
Group type: COMPARATOR
Intervention: Extraction alone (EXT)
Number of subjects: 24
Study 12931761 — intervention group
Group type: EXPERIMENTAL
Intervention: Ridge preservation (RP)
Number of subjects: 24
Study 11508686 — intervention group
Group type: EXPERIMENTAL
Intervention: Amtolmetin guacyl (AMG)
Number of subjects: 24
Study 11508686 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac
Number of subjects: 24
Study 11508686 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 11508686 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 24
Study 9713663 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal advice on exercise from the family physician and a pamphlet on exercise mailed to the patient's home address.
Number of subjects: 763
Study 9713663 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 763
Study 7976146 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV)
Number of subjects: 20
Study 7976146 — intervention group
Group type: COMPARATOR
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 20
Study 2512883 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic agents
Number of subjects: 0
Study 2512883 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary reperfusion
Number of subjects: 0
Study 1119679 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary closure
Number of subjects: 165
Study 1119679 — intervention group
Group type: EXPERIMENTAL
Intervention: Exteriorization
Number of subjects: 165
Study 1119679 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary colostomy
Number of subjects: 165
Study 1119679 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall management principles
Number of subjects: 165
Study 31109894 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG-IUS
Number of subjects: 358
Study 31109894 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 358
Study 30199658 — intervention group
Group type: EXPERIMENTAL
Intervention: Day-10 surrogate Hospital Anxiety and Depression Scale score
Number of subjects: 306
Study 30199658 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient unresponsiveness
Number of subjects: 306
Study 26575010 — intervention group
Group type: EXPERIMENTAL
Intervention: McGRATH
Number of subjects: 100
Study 26575010 — intervention group
Group type: COMPARATOR
Intervention: Macintosh
Number of subjects: 100
Study 25008402 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthopedic pillow
Number of subjects: 20
Study 25008402 — intervention group
Group type: COMPARATOR
Intervention: Memory foam pillow
Number of subjects: 20
Study 25008402 — intervention group
Group type: COMPARATOR
Intervention: Feather pillow
Number of subjects: 20
Study 22505280 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-ended non-valved PICC
Number of subjects: 102
Study 22505280 — intervention group
Group type: EXPERIMENTAL
Intervention: Groshong valve
Number of subjects: 102
Study 22505280 — intervention group
Group type: EXPERIMENTAL
Intervention: PASV valve
Number of subjects: 102
Study 20640501 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitrification
Number of subjects: 262
Study 20640501 — intervention group
Group type: COMPARATOR
Intervention: Slow-rate cryopreservation
Number of subjects: 262
Study 17958944 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (once-weekly)
Number of subjects: 48
Study 16148822 — intervention group
Group type: EXPERIMENTAL
Intervention: Molecular Adsorbents Recycling System (MARS)
Number of subjects: 354
Study 16148822 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy
Number of subjects: 354
Study 12484708 — intervention group
Group type: EXPERIMENTAL
Intervention: Echinacea (1-g doses six times on the first day and three times on each subsequent day for a maximum of 10 days)
Number of subjects: 148
Study 12484708 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 12484708 — intervention group
Group type: EXPERIMENTAL
Intervention: Echinacea
Number of subjects: 148
Study 9932945 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of regular-release levodopa (rr-L-dopa) and sustained-release levodopa (sr-L-dopa)
Number of subjects: 30
Study 9932945 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy with regular-release levodopa (rr-L-dopa)
Number of subjects: 30
Study 7474027 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily acupuncture in three auricular sites plus one body site (LI-4)
Number of subjects: 40
Study 7474027 — intervention group
Group type: COMPARATOR
Intervention: Control sites within 2-3 mm of the four active sites
Number of subjects: 40
Study 2185575 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol combined with diltiazem
Number of subjects: 32
Study 2185575 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol combined with nifedipine
Number of subjects: 32
Study 375733 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical therapy with Nonoxynol 9
Number of subjects: 69
Study 375733 — intervention group
Group type: COMPARATOR
Intervention: Initial genital HSV infection
Number of subjects: 69
Study 375733 — intervention group
Group type: COMPARATOR
Intervention: Initial infections
Number of subjects: 69
Study 375733 — intervention group
Group type: COMPARATOR
Intervention: Type 1 HSV
Number of subjects: 69
Study 375733 — intervention group
Group type: COMPARATOR
Intervention: Clinical recurrences
Number of subjects: 69
Study 375733 — intervention group
Group type: COMPARATOR
Intervention: Papanicolaou smears
Number of subjects: 69
Study 375733 — intervention group
Group type: COMPARATOR
Intervention: Cytologic smears
Number of subjects: 69
Study 375733 — intervention group
Group type: COMPARATOR
Intervention: Serology
Number of subjects: 69
Study 30836166 — intervention group
Group type: EXPERIMENTAL
Intervention: 78 Gy in 39 fractions of photon radiation therapy
Number of subjects: 301
Study 30836166 — intervention group
Group type: COMPARATOR
Intervention: 70 Gy in 35 fractions of photon radiation therapy
Number of subjects: 301
Study 27705097 — intervention group
Group type: EXPERIMENTAL
Intervention: Transareola single-site endoscopic thyroidectomy
Number of subjects: 40
Study 27705097 — intervention group
Group type: COMPARATOR
Intervention: Three-port endoscopic thyroidectomy
Number of subjects: 40
Study 26500170 — intervention group
Group type: EXPERIMENTAL
Intervention: CSM referral letter alone
Number of subjects: 0